Hemab
0 followers
About Hemab
Hemab is a biotechnology company pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
Recent News
Seaport, Hemab Price IPOs, While Avalyn Soars in Nasdaq Debut
The IPO Pipeline Finally Gets Interesting
Hemab Therapeutics (COAG) IPO Deck
Biotech’s IPO Tide Is Finally Turning, Thanks in Part to the Recent M&A Surge
Hemab Therapeutics Upsizes IPO to $346.7 Million, Led by Goldman Sachs, Jefferies and Evercore
The IPO Buzz: Hemab Therapeutics (COAG) Prices Upsized IPO at $18 – Top – & Stock Pops
FDA Approves the First PROTAC in History, a $1B siRNA Wave Hits Cardiometabolic Disease, and Cytokinetics Cracks Non-Obstructive HCM – This Week in Biotech #99